Weekly Recap: FDA 510(k) clearance for TriNav Advance and TLSI stock rally
TriSalus Life Sciences, Inc. (NASDAQ:TLSI) jumped about 6% after FDA 510(k) clearance for TriNav Advance, which expands PEDD use to small distal vessels and more embolizations, with a limited market release planned in coming weeks as the stock trades in the mid-$5s near $6 resistance.Previous Week…